The recommended dosage of Cosentyx (secukinumab) can be affected by a patient's weight. Cosentyx is a medication used to treat several conditions, including plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis [1].

For patients with a body weight of 100 kg (220 lbs) or less, the recommended dosage of Cosentyx is 300 mg by subcutaneous injection [2]. This dosage is typically administered as two 150 mg injections at different sites on the body [1].

However, for patients with a body weight greater than 100 kg (220 lbs), a higher dosage of Cosentyx may be recommended. Specifically, the recommended dosage for these patients is 300 mg by subcutaneous injection, administered once weekly for five weeks, followed by 300 mg every four weeks [2].

It is important to note that the dosage of Cosentyx may be adjusted based on the patient's individual needs and response to treatment [1]. Patients should consult with their healthcare provider to determine the appropriate dosage for their specific situation.

In summary, the recommended dosage of Cosentyx is affected by a patient's weight, with higher dosages recommended for patients who weigh more than 100 kg (220 lbs).

Sources:

1. Cosentyx (secukinumab) [Prescribing Information]. Novartis Pharmaceuticals Corporation; 2021. Available at: <https://www.novartis.us/sites/www.novartis.us/files/cosentyx.pdf>.
2. DrugPatentWatch. Cosentyx (secukinumab) [Dosage]. Available at: <https://www.drugpatentwatch.com/drugs/cosentyx>.